Replies to post #303686 on Innovation Pharmaceuticals Inc (IPIX)

[Lemoncat]

The answer, Pete, is risk aversion.

You're asking me with no grant money (yet), if I would take $8B ($24/share) for my $135M ($0.46/share) company. The answer is yes.

I don't care if there was a theoretical $100/share dividend in your projection. $24/share means instant retirement and multi-generational wealth locked in with no risk for me. I would lock that in with no fear of what I missed out 100/100 times.

That's not to say that we can't get to the values you espouse. But there is uncertainty there.

I think if a big pharma came to Leo with that deal on Monday, he would cash out as a billionaire and never look back. Maybe he'd then form a new company and snatch up some of the indications for Brilacidin that we gave up.

Go IPIX!

[GreenBioAnalyst]

Maybe it's because business is not your cup of tea? If any type of business arrangement, startup or not, you have two options: exit (sell) or persevere. But you would not know that since neither science nor business (background) you possess or is your strength.

You always weigh those two options above no matter what and you maintain an open mind.
Kevetrin anyone? LOL.

[loanranger]

Dividends are a rarity in small cap pharma land. Profits, where they exist, are retained versus paid out. Do you have any examples?
I think that's a fair real world question.

Somehow you seem to have convinced yourself that IPIX and Leo have more to offer than the marketplace that you hope to use for a source of funds finds apparent. The AlfaSigma deal, for example....from several days after the 8-K was filed:
"To secure such an agreement, why would anyone think Leo did not secure a significant upfront payment that should take care of our future needs (or at least until the OM deal is signed) to advance the oral formulations for both Brilacidin and Kevetrin? An upfront payment of only $20MM+ on UP/UPS away and above what they originally wanted to spend would prove a drop in the bucket to help them secure favored position with Leo for all of Brilacidin and result in the likely future revenues in the many,many billions. I believe the secrecy with upfront payment is per AS demands so nobody knows how tight they are with IPIX in regards to future bids for indications. Does anyone really believe Leo gave away the deal for single digit $MM or close to it?"

You were right. He didn't.

But if you have an example or two of small drug developers that pay out basically all the royalties they earn from developed products without retaining any funds for new development I'm happy to listen.

[attilathehunt]

A person with only 10K shares $100K/yr. "

How long is B and K patent protected?

[cybermich]

All I can say.. is that I hope that your numbers turn out to be true:)

Because when this is all said and done.. I am reserving a certain amount of shares (as I said before) for the end game..

I have always been a B liever.. and I originally invested for the promise of K.. so if both B and K turn out to be monster profit makers year and year out.. it definitely would be generational income.

You got to know (and you stated as much in your post) that only a percentage of those who own shares today will probably be here for the ultimate pay day..

I may not have as many shares as you:) but you will see me there.

Good luck to all longs (no matter where you choose to sell:)